- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat ; volume:20 ; number:1 ; day:6 ; month:9 ; year:2019 ; pages:1-9 ; date:12.2019
Respiratory research ; 20, Heft 1 (6.9.2019), 1-9, 12.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-019-1161-4
- URN
-
urn:nbn:de:101:1-2020012320562112112436
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maher, Toby M.
- Strek, Mary E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Idiopathic pulmonary fibrosis: moving forward
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Idiopathic pulmonary fibrosis: moving forward
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Idiopathic pulmonary fibrosis: moving forward
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis